NovaBay Pharmaceuticals, Inc.
NBY
$0.60
$0.000.00%
AMEX
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1,869.07% | -44.59% | 3.33% | -58.80% | -37.65% |
Total Receivables | -19.79% | -44.74% | 28.70% | -25.48% | 7.94% |
Inventory | -- | 53.61% | -28.86% | 4.95% | 33.13% |
Prepaid Expenses | -40.41% | 4.32% | 14.91% | -40.59% | 5.86% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -8.86% | 36.21% | 23.40% | -2.08% | -96.56% |
Total Current Assets | 367.08% | -15.09% | 1.15% | -37.26% | -49.80% |
|
|||||
Total Current Assets | 367.08% | -15.09% | 1.15% | -37.26% | -49.80% |
Net Property, Plant & Equipment | -64.78% | -8.61% | -7.78% | -7.21% | -6.80% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -0.21% | -3.03% | 3.99% | -0.21% | -4.02% |
Total Assets | 188.40% | -11.71% | -1.22% | -26.73% | -40.70% |
|
|||||
Total Accounts Payable | 28.41% | 57.32% | -67.94% | 10.56% | 23.29% |
Total Accrued Expenses | -15.21% | 94.19% | -24.43% | 0.58% | -55.43% |
Short-term Debt | -85.13% | 1,007.84% | -92.67% | -30.88% | -11.43% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.26% | 2.05% | 2.09% | 1.87% | 1.90% |
Total Finance Division Other Current Liabilities | 131.15% | -35.02% | -2.85% | -14.49% | 29.51% |
Total Other Current Liabilities | 131.15% | -35.02% | -2.85% | -14.49% | 29.51% |
Total Current Liabilities | 7.88% | 43.30% | -45.04% | -8.00% | -8.27% |
|
|||||
Total Current Liabilities | 7.88% | 43.30% | -45.04% | -8.00% | -8.27% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -85.13% | 1,007.84% | -92.67% | -30.88% | -11.43% |
Capital Leases | -10.01% | -13.64% | -11.91% | -10.47% | -6.05% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -30.54% |
Total Liabilities | 4.31% | 26.63% | -38.24% | -12.60% | -9.14% |
|
|||||
Common Stock & APIC | -0.75% | 0.01% | 2.18% | 1.29% | 0.51% |
Retained Earnings | 4.18% | -0.67% | -1.23% | -0.89% | -2.06% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 4,663.70% | -112.66% | 271.11% | 52.98% | -197.14% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | -99.60% | -23.85% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | -99.60% | -23.85% |
|
|||||
Total Common Equity | 4,663.70% | -112.66% | 271.11% | 52.98% | -197.14% |
Total Preferred Equity | 0.00% | 0.00% | 0.00% | -99.60% | -23.85% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 4,880.62% | -112.03% | 273.74% | -485.63% | -95.17% |
|